Roberto Guerrieri

This inventor holds 28 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 12 EPO patents, primarily in Biological Analysis. Top assignees: Stmicroelectronics S.r.l., Cellply S.r.l., Silicon Biosystems S.p.a.. Active years: 1995-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roberto Guerrieri. Retrieved from https://idiyas.com/inventor/roberto-guerrieri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 1)

% Patents Active = 85.7

CIPO Patents = 3

EPO Patents = 12 (Patent Applications = 6)

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 240(Granted Patents)

Location History:

Via Calari, IT (2014)
Bologna, IT (1995 - 2020)

Company Filing History:

13 out of 5,691

Stmicroelectronics S.r.l.

Silicon Biosystems S.p.a.

patents

4. 2 out of 2,891

Stmicroelectronics Gmbh

patents

5. 2 out of 16,025

University of California

patents

6. 1 out of 32

Menarini Silicon Biosystems, Inc.

patents

7. 1 out of 941

Sgs-Thomson Microelectronics S.r.l.

patents

Years Active: 1995-2020

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Cellular Function

Biological Particles

Electronic Devices

Communication Systems

High-Throughput Screening

FPGA Architectures

Digital Signal Processing

Pressure Sensors

Noise Compensation

Tire Features

Asynchronous Interconnection

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10571475 - Rapid screening of monoclonal antibodies (2020-02-25),

2. 10012579 - Microanalysis of cellular function (2018-07-03),

3. 9891157 - Microanalysis of cellular function (2018-02-13),

4. 9816910 - Microanalysis of cellular function (2017-11-14),

5. 9528981 - Diagnostic and therapeutic application of CTL and NK functionally selected cells (2016-12-27),

6. 9310334 - Method and apparatus for characterizing and counting particles, in particular biological particles (2016-04-12),

7. 9147636 - Method for verifying the alignment between integrated electronic devices (2015-09-29),

8. 9039883 - Method and apparatus for manipulating single cells and small aggregates thereof (2015-05-26),

9. 8992754 - Method and apparatus for the characterizing and counting particles, in particular, biological particles (2015-03-31),

10. 8679315 - Method and apparatus for characterizing and counting particles, in particular, biological particles (2014-03-25),

11. 8340576 - Electronic circuit for communicating through capacitive coupling (2012-12-25),

12. 8238502 - Communication system between a first and a second synchronous device that are uncorrelated in time (2012-08-07),

13. 8150315 - Method for verifying the alignment between integrated electronic devices (2012-04-03),

14. 7821293 - Asynchronous interconnection system for 3D interchip communication (2010-10-26),

15. 7808276 - Chip-to-chip communication system and method (2010-10-05),

Title: Innovative Contributions of Roberto Guerrieri in Biotechnological Patents

Introduction: Roberto Guerrieri, based in Bologna, Italy, is a notable inventor with a remarkable portfolio of 28 patents. His work focuses on advancements in biotechnology, particularly in the areas of monoclonal antibodies and cellular functions. Guerrieri's contributions have significantly impacted the field, enabling faster and more efficient methods of analyzing biological systems.

Latest Patents: Among his latest patents are two groundbreaking innovations. The first, titled "Rapid screening of monoclonal antibodies," outlines methods and systems for swiftly and effectively screening monoclonal antibodies and antibody-secreting cells. This patent emphasizes the utility of a microfluidic system, specifically an inverted open microwell system, where the particles remain unbound to any substrate. The second patent, "Microanalysis of cellular function," details an inverted microwell system designed for rapid microanalysis, allowing for the functional analysis of cells at a single-cell level. This innovation enables the identification of particles and biomolecules, enhancing therapeutic activities, especially for secreted antibodies, while also facilitating the recovery and optional expansion of antibody-secreting cells within the same microwell.

Career Highlights: Throughout his career, Guerrieri has made significant strides, particularly while working with notable companies such as STMicroelectronics and Cellply. His role in these organizations has been pivotal in translating innovative ideas into practical applications, fostering progress in the biotechnological landscape.

Collaborations: Guerrieri has collaborated with esteemed colleagues including Roberto Antonio Canegallo and Luca Magagni. Their teamwork has contributed to the successful development of various innovations, driving forward the capabilities of biotechnological research.

Conclusion: Roberto Guerrieri's extensive oeuvre of patents and his commitment to innovation in biotechnology underscore his importance as an inventor. Through his latest advancements in screening technologies and cellular functions, he continues to influence the industry, paving the way for future innovations that will enhance our understanding and application of biological processes.

Profile summary based on public USPTO records.